Retrospective Study of 573 Patients with Heart Failure Evaluated for Coronary Artery Disease at Toulouse University Center, France.


Journal

Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063

Informations de publication

Date de publication:
02 Jan 2022
Historique:
entrez: 2 1 2022
pubmed: 3 1 2022
medline: 15 3 2022
Statut: epublish

Résumé

BACKGROUND Heart failure (HF) most commonly occurs due to ischemic heart disease from stenotic coronary artery disease (CAD). HF is classified into 3 groups based on the percentage of the ejection fraction (EF): reduced (HFrEF), mid-range (HFmrEF), and preserved (HFpEF). This retrospective study included 573 patients who presented with HF based on the evaluation of EF and were evaluated for CAD by coronary angiography before undergoing coronary angioplasty at a single center in Toulouse, France. MATERIAL AND METHODS This retrospective observational study included patients recently diagnosed with HF or acute decompensation of chronic HF and referred for coronary angiography at Toulouse University Hospital between January 2019 and May 2020. RESULTS Significant CAD was found in 55.8%, 55%, and 55% of the whole population, HFpEF, and HFrEF groups, respectively. Older age, male sex, and diabetes mellitus were the main risk factors for ischemic HF. Except for age and sex, patients with ischemic HFpEF were comparable to those with non-ischemic HFpEF, unlike the ischemic HFrEF group, which had more common cardiovascular risk factors than the non-ischemic HFrEF group. The ischemic HFpEF group had an older age and higher rate of dyslipidemia than the ischemic HFrEF group. CONCLUSIONS At our center, CAD was diagnosed in more than half of patients who presented with heart failure with preserved or reduced EF. Older age and male sex were the common risk factors in patients with HFpEF and HFrEF.

Identifiants

pubmed: 34974513
pii: 934804
doi: 10.12659/MSM.934804
pmc: PMC8734094
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e934804

Références

Card Fail Rev. 2017 Apr;3(1):7-11
pubmed: 28785469
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2817-27
pubmed: 24768876
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Arch Cardiovasc Dis. 2018 Feb;111(2):109-118
pubmed: 29031580
JAMA Cardiol. 2021 Oct 1;6(10):1130-1143
pubmed: 34160566
Eur Heart J. 2001 Feb;22(3):228-36
pubmed: 11161934
Heart Fail Clin. 2014 Apr;10(2):353-65
pubmed: 24656111
Curr Cardiol Rev. 2020;16(1):55-64
pubmed: 31288726
Eur Heart J. 2019 Dec 14;40(47):3859-3868c
pubmed: 31800034
J Geriatr Cardiol. 2011 Mar;8(1):15-23
pubmed: 22783280
Cardiol Res Pract. 2020 Jul 29;2020:6527820
pubmed: 32802497
JAMA. 2020 Aug 4;324(5):488-504
pubmed: 32749493
Med Sci Monit. 2021 Feb 09;27:e928218
pubmed: 33558450
Eur J Heart Fail. 2009 May;11(5):472-9
pubmed: 19251729
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
Heart Fail Clin. 2019 Jan;15(1):19-27
pubmed: 30449377

Auteurs

Antoine Deney (A)

Department of Cardiology, Institute CARDIOMET, University Hospital of Toulouse, Toulouse, France.

Vanessa Nader (V)

Department of Cardiology, Institute CARDIOMET, University Hospital of Toulouse, Toulouse, France.
Faculty of Pharmacy, Lebanese University, Beirut, Lebanon.

Anthony Matta (A)

Department of Cardiology, Institute CARDIOMET, University Hospital of Toulouse, Toulouse, France.
Faculty of Medicine, Holy Spirit University of Kaslik, Kaslik, Lebanon.

Romain Itier (R)

Department of Cardiology, Institute CARDIOMET, University Hospital of Toulouse, Toulouse, France.

Pauline Fournier (P)

Department of Cardiology, Institute CARDIOMET, University Hospital of Toulouse, Toulouse, France.

Olivier Lairez (O)

Department of Cardiology, Institute CARDIOMET, University Hospital of Toulouse, Toulouse, France.

Nathalie Pizzinat (N)

National Institute of Health and Medical Research (INSERM) U1297, Toulouse, France.

Didier Carrié (D)

Department of Cardiology, Institute CARDIOMET, University Hospital of Toulouse, Toulouse, France.

Frédéric Boal (F)

National Institute of Health and Medical Research (INSERM) U1297, Toulouse, France.

Michel Galinier (M)

Department of Cardiology, Institute CARDIOMET, University Hospital of Toulouse, Toulouse, France.

Oksana Kunduzova (O)

National Institute of Health and Medical Research (INSERM) U1297, Toulouse, France.

Rania Azar (R)

Faculty of Pharmacy, Lebanese University, Beirut, Lebanon.

Jerome Roncalli (J)

Department of Cardiology, Institute CARDIOMET, University Hospital of Toulouse, Toulouse, France.
National Institute of Health and Medical Research (INSERM) U1297, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH